Associated Papers
Monogenic forms of inflammatory bowel disease: Genetic mechanisms, models, and clinical implications.
Ghorbanpour A et al.
Molecular Medicine (cambridge, Mass.), 2026
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S5
Congenital diarrhea and enteropathies caused by a heterozygous mutation in the GUCY2C gene: a rare case report.
Yuan C et al.
Frontiers in Pediatrics, 2025
The genetics of monogenic intestinal epithelial disorders.
Babcock SJ et al.
Human Genetics, 2023
Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C.
Mishra V et al.
The Journal of Experimental Medicine, 2021
Novel GUCY2C variant causing familial diarrhea in a Mennonite kindred and a potential therapeutic approach.
Wolfe RM et al.
American Journal of Medical Genetics. Part A, 2021
Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C.
Müller T et al.
Gut, 2016
Meconium ileus in a Lebanese family secondary to mutations in the GUCY2C gene.
Smith A et al.
European Journal of Human Genetics : Ejhg, 2015
Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies.
Canani RB et al.
Nature Reviews. Gastroenterology & Hepatology, 2015
Guanylate cyclase-C receptor activation: unexpected biology.
Brierley SM
Current Opinion in Pharmacology, 2012
Guanylate cyclase C signaling: an intestinal secretory pathway where bugs, genes and new drugs intersect.
Camilleri M
Genome Medicine, 2012
Familial diarrhea syndrome caused by an activating GUCY2C mutation.
Fiskerstrand T et al.
The New England Journal of Medicine, 2012
Select a paper to view details